Benzodiazepines by Remedi HS

FDA 510(k) K955116 · Bio-Rad

Substantially Equivalent

510(k) numberK955116

Submission

Device name
Benzodiazepines by Remedi HS
Applicant
Bio-Rad
Hercules, CA, US
Received
November 9, 1995
Decision date
January 30, 1996
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
LAA – High Pressure Liquid Chromatography, Benzodiazepine
Device class
Class II (moderate risk)
Regulation
21 CFR 862.3170
Specialty
Clinical Toxicology

More from Bio-Rad

510(k)DeviceDecision
K171061MRSASelect IIJSO · Traditional 12/28/2017SE
K122187Vreselect Culture MediumJSO · Traditional 11/06/2012SE
K103684Vreselect Culture MediumJSO · Traditional 10/21/2011SE
K093678Platelia Aspergillus Eia Model 62793NOM · Traditional 01/13/2011SE
K100589Mrsa Select - Skin and Soft Tissue Wound SpecimensJSO · Traditional 10/29/2010SE
K081362Platelia Lyme IgmLSR · Traditional 06/26/2008SE
K081212Mrsaselect - Extended IncubationJSO · Traditional 06/13/2008SE
K080012Platelia Lyme Igg AssayLSR · Traditional 05/08/2008SE
K070361MrsaselectJSO · Traditional 09/13/2007SE
K060641Platelia Aspergillus Eia, Model 62793NOM · Traditional 06/02/2006SE

Questions and answers

When was Benzodiazepines by Remedi HS cleared by the FDA?

Benzodiazepines by Remedi HS (K955116) received a 510(k) decision of Substantially Equivalent on January 30, 1996, 82 days after the submission was received.

What is the product code of K955116?

The FDA product code is LAA – High Pressure Liquid Chromatography, Benzodiazepine, a Class II (moderate risk) device regulated under 21 CFR 862.3170.